Search research articles
Contact Us
Filters
Showing results (171-180 of 196) with videos related to
Page
of 20
Sort By:
Science Advances
|
September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
Kai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood
|
April 22, 2016
Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
Simon Völkl, Anne Rensing-Ehl, Andrea Allgäuer, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
Hannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
Hemasphere
|
July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Veit Bücklein, Ariel Perez, Kai Rejeski, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
The New England Journal of Medicine
|
February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
Fabian Müller, Jule Taubmann, Laura Bucci, et al.
Blood
|
September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Annals of the Rheumatic Diseases
|
July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissue
Carlo Tur, Markus Eckstein, Laura Bucci, et al.
Frontiers in Immunology
|
November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
Armin Gerbitz, Regina Gary, Michael Aigner, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 196) with videos related to
Sort By:
Page
of 20
Science Advances
|
September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
Kai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Blood
|
April 22, 2016
Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
Simon Völkl, Anne Rensing-Ehl, Andrea Allgäuer, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal for Immunotherapy of Cancer
|
June 26, 2021
Identification and validation of expressed HLA-binding breast cancer neoepitopes for potential use in individualized cancer therapy
Hannah Reimann, Andrew Nguyen, J Zachary Sanborn, et al.
Hemasphere
|
July 14, 2023
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use
Veit Bücklein, Ariel Perez, Kai Rejeski, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
The New England Journal of Medicine
|
February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
Fabian Müller, Jule Taubmann, Laura Bucci, et al.
Blood
|
September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma
Lorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Annals of the Rheumatic Diseases
|
July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissue
Carlo Tur, Markus Eckstein, Laura Bucci, et al.
Frontiers in Immunology
|
November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
Armin Gerbitz, Regina Gary, Michael Aigner, et al.
Page
of 20